Identification and roles of mir-29b-1-3p and mir29a-3p-regulated and non-regulated lncrnas in endocrine-sensitive and resistant breast cancer cells

Keyphrases

• Breast Cancer Cells 100%
• MiR-29a 100%
• MiR-29b 100%
• Resistant Breast Cancer 100%
• Long Non-coding RNA (LncRNA) 100%
• Non-coding RNA (ncRNA) 40%
• MCF-7 40%
• Endocrine Resistance 40%
• Differentially Expressed lncRNAs 40%
• Combination Therapy 20%
• Cell Proliferation 20%
• Overexpression 20%
• MicroRNA 20%
• Estrogen Receptor 20%
• Breast Cancer Survival 20%
• Metastasis 20%
• Metastatic Disease 20%
• Primary Tumor 20%
• Exosomal 20%
• Low Expression 20%
• Survival Analysis 20%
• Expression Pattern 20%
• Resistant Cells 20%
• RNA Sequencing (RNA-seq) 20%
• Cell Signaling Pathways 20%
• MCF-7 Cells 20%
• Target Pattern 20%
• Tamoxifen Resistance 20%
• TCGA Database 20%
• Endocrine-resistant Breast Cancer 20%
• SNHG5 20%
• GAS5 20%
• KM Plotter 20%
• DANCR 20%
• DSCAM-AS1 20%

Medicine and Dentistry

• Breast Cancer 100%
• Cancer Cell 100%
• microRNA 29b 100%
• MCF-7 75%
• Metastatic Carcinoma 50%
• microRNA 29a 50%
• Tamoxifen 50%
• Combination Therapy 25%
• RNA Sequencing 25%
• Cell Signaling Pathway 25%
• microRNA 25%
• Untranslated RNA 25%
• Breast Cancer Survival 25%
• Survival Analysis 25%
• Cell Proliferation 25%
• Primary Tumor 25%
• Long Untranslated RNA 25%
• microRNA 29 25%
• The Cancer Genome Atlas 25%
• Estrogen Receptor 25%

Biochemistry, Genetics and Molecular Biology

• Signal Transduction 100%
• Cancer Cell 100%
• MicroRNA 50%
• RNA Sequencing 50%
• Cancer Survival 50%
• Cell Proliferation 50%
• Down Syndrome Cell Adhesion Molecule 50%
• GAS5 50%
• Estrogen Receptor 50%
• Non-Coding RNA 50%
• Long Non-Coding RNA 50%